Migrants have been long identified as one of the populations with highest vulnerability to HIV infection and its consequences. Migrants encompass heterogeneous groups of persons with different migration drivers – economic, social, political, cultural and environmental – as well as with distinct risk-contexts for HIV infection. Some migrant groups have a disproportionate burden of HIV infection which often exhibits distinct gender patterns. The relative contribution of migrants to national epidemics varies across the world, the highest being in Europe and Asia. Between 2007 and 2012 nearly two-fifths of all HIV cases reported in the European Union/European Economic Area were of migrant origin; the commonest being Sub-Saharan Africa, other European countries and Latin-America & The Caribbean. The epidemiological patterns of HIV in these migrants resembles that of the countries of origin; with a highly feminized and fundamentally heterosexually acquired epidemic in migrants from Sub-Saharan Africa and a very high proportion of Men who have sex with Men (MSM) among the cases from Latin-America. HIV infection can be acquired in the pre and post-migration phases as well as in the migratory transit; circular migration is of relevance in some settings such as the US/Mexican border. There is increasing evidence of the higher risk of HIV acquisition among migrant MSM in the post-migration phase, highlighting the sexual diversity of the migrant population.Most migrant groups, particularly the undocumented, experience difficulties to access HIV testing and health care. Further, in most countries undocumented migrants are not entitled to antiretroviral treatment (ART). As a consequence, late HIV diagnosis and presentation are commoner among migrants who also exhibit lower CD4 cell counts at ART initiation and poorer immunological and virological responses. Access to ART is one of the pillars of the end of AIDS UNAIDS strategy. It has been firmly established how early HIV diagnosis and linkage to care are beneficial at individual and community levels but this all relies in universal and equitable access to ART. Finally, effective implementation of large-scale treatment programs cannot be achieved without a global commitment to guarantee access to ART for all persons living with HIV which does not leave a subset of the population behind.